OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
Konstantinos Gousias, Theocharis Theocharous, Matthias Simon
Biomedicines (2022) Vol. 10, Iss. 3, pp. 564-564
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Role of CXCL13 in GC‐1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Through JAK2/STAT3 Signaling Pathway
Yuzhu Lei, Ruoyun Dong, Chun-Yan Sun, et al.
Journal of Applied Toxicology (2025)
Closed Access

Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders
Marc J. Kaufman, Edward G. Meloni
Medical Gas Research (2025)
Closed Access

Phytochemicals in Cancer Therapy: Modulating Cell Cycle, Angiogenesis, and Epithelial-Mesenchymal Transition
Sheikh Showkat Ahmad, Chandni Garg, Aashaq Hussain Bhat, et al.
Revista Brasileira de Farmacognosia (2025)
Closed Access

Personalised therapeutic approaches to glioblastoma: A systematic review
Oliver Mowforth, Jamie Brannigan, Marc El Khoury, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 15

Novel Clinical Trials and Approaches in the Management of Glioblastoma
Allison R. Valerius, Lauren M. Webb, Uğur Sener
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 439-465
Closed Access | Times Cited: 4

Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer
Md. Ariful Islam, Md. Bayazid Hossen, Md. Abu Horaira, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1369-1369
Open Access | Times Cited: 14

The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs
Nima Rastegar‐Pouyani, Vahideh Montazeri, Nikoo Marandi, et al.
Cancer Investigation (2023) Vol. 41, Iss. 7, pp. 656-671
Closed Access | Times Cited: 10

Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling
Alessia Filippone, Giovanna Casili, Sarah Adriana Scuderi, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 217-217
Open Access | Times Cited: 17

Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2

Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro
Seyed Ali Shariat Razavi, Masoumeh Taghdisi Khaboushan, Raha Jafari, et al.
Physiological Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2

Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma
Jie Liu, Yung‐Ting Chang, Yan-Yu kou, et al.
Medical Oncology (2024) Vol. 41, Iss. 9
Closed Access | Times Cited: 2

Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors
Hany M. Abd El‐Lateef, Ahmed Gaafar Ahmed Gaafar, Arwa Sultan Alqahtani, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24781-24790
Open Access | Times Cited: 2

Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood–brain–barrier in a glioblastoma model
Fatemeh Madani, Hassan Morovvati, Thomas J. Webster, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

The role of BCL2L13 in glioblastoma: turning a need into a target
Joadi Jacobs, Rosa Iranpour, Amir Barzegar Behrooz, et al.
Biochemistry and Cell Biology (2023) Vol. 102, Iss. 2, pp. 127-134
Open Access | Times Cited: 7

Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy
Ani-Simona Sevastre, Elena Victoria Manea, Oana Stefana Popescu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9943-9943
Open Access | Times Cited: 11

Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies
Omar Tluli, Mazyona Al-Maadhadi, Aisha Abdulla Al-Khulaifi, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4213-4213
Open Access | Times Cited: 5

Combined oncolytic virotherapy gold nanoparticles as synergistic immunotherapy agent in breast cancer control
Majid S. Jabir, Ahmed Majeed Al-Shammari, Zainab O. Ali, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

An arresten-derived anti-angiogenic peptide triggers apoptotic cell death in endothelial cells
Reyhane Chamani, Omid Saberi, Fatemeh Fathinejad
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1

Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review
Sashana Dixon, Ann Tenneil O’Connor, Chloe Brooks-Noreiga, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 1, pp. 1-23
Closed Access | Times Cited: 1

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach
Ali Kaynar, Woonghee Kim, Atakan Burak Ceyhan, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2237-2237
Open Access | Times Cited: 1

d-limonene-loaded liposomes target malignant glioma cells via the downregulation of angiogenic growth factors
Vinitha Rani, Jayachandran Venkatesan, Ashwini Prabhu
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104358-104358
Closed Access | Times Cited: 4

Titanium Dioxide Nanoparticles Induce Cell Cycle Arrest and Apoptosis through Inhibiting PI3K/AKT/mTOR Pathway in Spermatogonia
Ruoyun Dong, Xiaojia Meng, Hongmei Chang, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 9, pp. 4065-4077
Closed Access | Times Cited: 4

Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat
Stefania Elena Navone, Laura Guarnaccia, Massimiliano D. Rizzaro, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 130-130
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top